Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating animal babesiasis

A pyrosomiasis and composition technology, applied in the field of pharmaceutical compositions, can solve the problems of high toxicity and side effects, low safety index, etc., and achieve the effects of blocking the metabolism of worms, reducing persistent high fever, and accelerating the function of the gastrointestinal tract

Inactive Publication Date: 2016-05-18
王树青
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, injections such as acaprine, midazolone, and artemether are generally used to treat animal pyroglycosis, but side effects such as restlessness in standing and lying, muscle tremors, salivation, sweating, and dyspnea often occur, and the safety index is low. The side effects are large, and various symptoms cannot be effectively relieved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating animal babesiasis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0009] A pharmaceutical composition for treating animal pyrosomiasis, which is composed of the following raw materials: 110g of Artemisia annua, 90g of Capillary, 90g of Rhubarb, 90g of Gentiana, 90g of Bupleurum, 90g of Chinese Angelica, 50g of Akebia, and 50g of Alisma , Atractylodes macrocephala 60g, Poria cocos 60g, licorice 50g.

[0010] When using, add 1.5-2 times the amount of water (the amount of water is preferably 2-3cm soaked in the drug) and decoct for 30 minutes, 200-500ml per head of affected cattle, 1 dose per day, consecutively for 5 days; 100-200ml, 1 dose per day, for 5 consecutive days. When other animals are used, the usage amount of the pharmaceutical composition is adjusted according to the weight ratio of cattle and sheep.

Embodiment 2

[0012] A pharmaceutical composition for treating animal pyrosomiasis, which is composed of the following raw materials: 105g of Artemisia annua, 95g of Capillary chinensis, 95g of rhubarb, 100g of gentian, 100g of bupleurum, 100g of wine angelica, 45g of akebia, and 50g of Alisma , Atractylodes macrocephala 60g, Poria cocos 50g, licorice 40g.

[0013] When using, add 1.5-2 times the amount of water (the amount of water is preferably 2-3cm soaked in the drug) and decoct for 30 minutes, 200-500ml per head of affected cattle, 1 dose per day, consecutively for 5 days; 100-200ml, 1 dose per day, for 5 consecutive days. When other animals are used, the usage amount of the pharmaceutical composition is adjusted according to the weight ratio of cattle and sheep.

Embodiment 3

[0015] A pharmaceutical composition for treating animal pyrosomiasis, which is composed of the following raw materials: 100g of Artemisia annua, 100g of Capillary chinensis, 90g of rhubarb, 95g of gentian, 95g of bupleurum, 90g of wine angelica, 50g of akebia, and 45g of Alisma , Atractylodes macrocephala 50g, Poria cocos 60g, licorice 45g.

[0016] When using, add 1.5-2 times the amount of water (the amount of water is preferably 2-3cm soaked in the drug) and decoct for 30 minutes, 200-500ml per head of affected cattle, 1 dose per day, consecutively for 5 days; 100-200ml, 1 dose per day, for 5 consecutive days. When other animals are used, the usage amount of the pharmaceutical composition is adjusted according to the weight ratio of cattle and sheep.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating animal babesiasis. The pharmaceutical composition consists of artemisia apiacea, Tibetan capillary, rheum officinale, gentian, radix bupleuri, Chinese angelica root, akebia stem, rhizoma alismatis, rhizoma atractylodis macrocephalae, poria cocos and liquorice, wherein the artemisia apiacea is used for preventing malaria and clearing heat; the Tibetan capillary, rheum officinale, gentian and the like have the functions of removing toxicity, eliminating dampness and removing jaundice; the rhizoma alismatis and akebia stem have the functions of discharging heat and inducing diuresis; the radix bupleuri is used for soothing the liver and clearing heat while the Chinese angelica root is used for tonifying and activating blood; and the poria cocos and rhizoma atractylodis macrocephalae are used for invigorating the spleen and promoting appetite. The traditional Chinese medicine components supplement each other and cooperate to generate a synergistic effect to inhibit the DNA synthesis of babesiasis matrix, block metabolism in the babesiasis and inhibit the growth and propagation thereof, so that various symptoms such as alternate lasting high fever, anemia, jaundice, constipation and diarrhea as well as obvious emaciation of the ill animals can be effectively relieved; moreover, the pharmaceutical composition has the functions of clearing heat and removing toxicity, promoting bile secretion and dispelling babesiasis, discharging heat and cooling blood, nourishing yin and moistening dryness, activating blood and resolving stasis and tonifying blood and invigorating the stomach, and can realize perfect effects of invigorating the stomach, regulating qi and tonifying deficiency and accelerate the recovery of gastrointestinal function after babesiasis dispelling; and by reinforcing healthy qi and eliminating pathogen and treating both symptoms and root causes, the pharmaceutical composition is safe without side effects.

Description

technical field [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating animal pyrosomiasis. Background technique [0002] Pyrosomiasis is a kind of protozoan disease caused by pyrozoites parasitizing in animal red blood cells and reticuloendothelial cells, and it is a natural foci disease. In addition to cattle and sheep, the animals it infects include equine animals, dogs, pigs, etc., and sometimes it can infect humans, but the most important target of the disease is cattle and sheep. Since 1995, the disease has been very prevalent in Tianzhu County, Gansu Province, especially in towns such as Tanshanling, Saishisi, Tiantang, and Sailalong. The incidence rate of calves is about 44%, and the fatality rate is 35%. In order to investigate clearly the types of coyoriasis and infectious agents in Tianzhu white yaks, serum and anticoagulant blood samples were collected from white yaks in the high-incidence areas o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/884A61P33/02
CPCA61K9/0095A61K36/076A61K36/185A61K36/232A61K36/233A61K36/28A61K36/282A61K36/284A61K36/484A61K36/515A61K36/708A61K36/884A61K2236/331A61K2300/00Y02A50/30
Inventor 王树青马玉珍
Owner 王树青
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com